Purpose: Postoperative Propionibacterium endophthalmitis is a conditio
n characterized by exacerbations and remissions that has often been ac
companied by recurrence after treatment. The purpose of this study is
to evaluate the efficacy of initial therapies in preventing recurrent
endophthalmitis and to assess the safety of intraocular lens (IOL) exc
hange performed during treatment of active endophthalmitis. Methods: T
he records of 22 patients with culture-proven Propionibacterium endoph
thalmitis treated at one facility were retrospectively reviewed. Resul
ts: Two patients presented acutely, were treated with intraocular anti
biotic injection alone, and experienced no recurrent inflammation. Twe
nty patients presented with chronic, delayed-onset pseudophakic endoph
thalmitis. Eight of these were treated initially with intraocular anti
biotic injection alone, and recurrent endophthalmitis developed in sev
en. Twelve patients with chronic endophthalmitis were initially manage
d surgically with either pars plana vitrectomy or IOL exchange. Four o
f the 12 experienced recurrent endophthalmitis. Patients undergoing ca
psulectomy as part of initial management experienced the lowest rate o
f recurrent endophthalmitis. Eight patients eventually underwent total
capsulectomy and IOL explantation, seven of whom had IOL exchange. No
ne of these eight patients had recurrent endophthalmitis. In seven of
the eight, persistent bacterial colonization of the lens capsular remn
ants was demonstrated. Conclusions: These data suggest that recurrent
Propionibacterium endophthalmitis is due to persistence of viable orga
nisms sequestered within lens capsular remnants, and that initial ther
apy directed toward surgical removal of these sequestered organisms re
sults in a reduced frequency of recurrent endophthalmitis. Intraocular
lens exchange with complete capsular removal during active endophthal
mitis was not associated with recurrent or persistent endophthalmitis.